ICUI vs. ATRI, HAE, MMSI, PRCT, IART, TNDM, NARI, ATEC, LMAT, and ATRC
Should you be buying ICU Medical stock or one of its competitors? The main competitors of ICU Medical include Atrion (ATRI), Haemonetics (HAE), Merit Medical Systems (MMSI), PROCEPT BioRobotics (PRCT), Integra LifeSciences (IART), Tandem Diabetes Care (TNDM), Inari Medical (NARI), Alphatec (ATEC), LeMaitre Vascular (LMAT), and AtriCure (ATRC). These companies are all part of the "surgical & medical instruments" industry.
ICU Medical (NASDAQ:ICUI) and Atrion (NASDAQ:ATRI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, community ranking, dividends, risk, institutional ownership, media sentiment and analyst recommendations.
ICU Medical received 254 more outperform votes than Atrion when rated by MarketBeat users. Likewise, 64.48% of users gave ICU Medical an outperform vote while only 56.09% of users gave Atrion an outperform vote.
Atrion has a net margin of 11.46% compared to ICU Medical's net margin of -1.31%. Atrion's return on equity of 8.07% beat ICU Medical's return on equity.
ICU Medical currently has a consensus price target of $123.00, suggesting a potential upside of 14.62%. Given ICU Medical's higher possible upside, equities analysts plainly believe ICU Medical is more favorable than Atrion.
In the previous week, Atrion had 5 more articles in the media than ICU Medical. MarketBeat recorded 6 mentions for Atrion and 1 mentions for ICU Medical. ICU Medical's average media sentiment score of 1.87 beat Atrion's score of 0.32 indicating that ICU Medical is being referred to more favorably in the media.
Atrion has lower revenue, but higher earnings than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than Atrion, indicating that it is currently the more affordable of the two stocks.
96.1% of ICU Medical shares are held by institutional investors. Comparatively, 66.2% of Atrion shares are held by institutional investors. 7.5% of ICU Medical shares are held by insiders. Comparatively, 22.7% of Atrion shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
ICU Medical has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, Atrion has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.
Summary
Atrion beats ICU Medical on 9 of the 17 factors compared between the two stocks.
Get ICU Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ICU Medical Competitors List
Related Companies and Tools